Skip to content
Screener

Repligen RGEN Total Current Assets

Total Current Assets at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$23.37B-5.0%
Danaher logo
DanaherDHR
$13.38B+21.7%
Maravai LifeSciences Holdings, Inc. logo
Maravai LifeSciences Holdings, Inc.MRVI
$251.74M-33.1%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$2.94B-3.1%
Charles River Laboratories logo
Charles River LaboratoriesCRL
$1.53B+4.0%
TEC
Bio-TechneTECH
$688.05M+9.7%

Other financials

Income statement

See full
Revenue$204.1M+11.9%
Gross profit$110.0M+20.7%
Operating income$14.0M+0.6%
Net income$5.0M-66.3%
EPS (diluted)$0.09-65.4%

Balance sheet

See full
Cash & equivalents$606.8M-14.4%
Total debt$690.9M+354%
Total equity$2.1B+2.4%
Total assets$3.0B+1.7%

Cash flow

See full
Operating cash flow$32.8M+14.5%
CapEx$5.3M-24.9%
Free cash flow$27.4M+27.5%

Valuation

See full
Market cap$8.95B+42.1%
Enterprise value$9.03B+57.3%
P/E215.5×
P/S11.6×+0.3×

Profitability

See full
Gross margin47.6%+0.9pp
Operating margin15.6%-11.0pp
Net margin17.3%-3.5pp
FCF margin22%+6.9pp

Returns & leverage

See full
Return on equity2%+1.6pp
Debt / equity0.3×+0.3×
Current ratio9.1×+0.5×

Where this comes from

Reported directly by Repligen in its filing.

Tagged under the XBRL concept us-gaap:AssetsCurrent.

The source filing: Repligen’s 10-Q, filed July 29, 2026.

Filed
Jul 29, 2026, 4:19 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-323773
Line itemJune 30, 2026December 31, 2025
Accounts receivable, net of allowances of $3,099 and $2,767 at June 30, 2026 and December 31, 2025, respectively157,710158,587
Inventories, net186,604170,458
Prepaid expenses and other current assets45,79140,712
Total current assets1,200,5541,137,385
Property, plant and equipment, net167,513186,614
Intangible assets, net357,622386,147
Goodwill1,104,1831,114,408
Deferred tax assets700694

ITEM 1. Financial Statements

FAQ

What is Repligen's total current assets?
Repligen (RGEN) reported total current assets of $1.2B in Q2 2026.
How has Repligen's total current assets changed year-over-year?
Repligen's total current assets increased by 13.6% year-over-year, from $1.06B to $1.2B.
What is the long-term trend for Repligen's total current assets?
Over 5 years (2020 to 2025), Repligen's total current assets has grown at a 4.7% compound annual growth rate (CAGR), from $902.38M to $1.14B.
What does total current assets mean?
The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.

Ask your AI about Repligen's total current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude